NEWS SOURCE

BioPharma Dive

Latest news articles from BioPharma Dive, tracked in real-time by Catalayer.

Replimune takes third swing at cancer drug approval following ‘productive’ FDA talks - BioPharma Dive
2026-05-29
Ready to explore Catalayer?
Explore the platform, or bring us your next product idea.
Explore ProductsStart Free Trial